Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BERTHA Study: Rheumatoid Arthritis-Associated Interstitial Lung Disease: Characterization of Lung Disease Progression. A Multicenter, Observational Study

NCT04136223 is registered in ClinicalTrials.gov with Hospital do Coracao as lead sponsor.

NCT NCT04136223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04136223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BERTHA Study: Rheumatoid Arthritis-Associated Interstitial Lung Disease: Characterization of Lung Disease Progression. A Multicenter, Observational Study
Lead sponsor
Hospital do Coracao
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2021
Completion date
May 31, 2024
Enrollment
100 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease, pulmonary fibrosis, rheumatoid arthritis, rheumatoid lung